Wells Fargo’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Wells Fargo’s Portfolio FURX Stock Details FURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,881	Closed	-$200K	–	6630
2014 Q2	$200K	Buy	1,881 +1,661	+755%	+$163K	﹤0.01%	4378
2014 Q1	$20K	Buy	220 +47	+27%	+$3.63K	﹤0.01%	5239
2013 Q4	$8K	Buy	173 +64	+59%	+$2.63K	﹤0.01%	5260
2013 Q3	$5K	Sell	109 -7	-6%	-$290	﹤0.01%	5311
2013 Q2	$4K	Buy	+116	New	+$4.07K	﹤0.01%	5279

Wells Fargo's FURX Position: Q3 2014 in Review

Wells Fargo sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 1,881 shares — an estimated $200K sold.

Wells Fargo first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $200K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

Wells Fargo reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
Wells Fargo sold 1,881 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $200K.
Wells Fargo first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
Wells Fargo's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $200K in Q2 2014.
0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Wells Fargo's 13F filing for Q3 2014, filed 6 Nov 2014.